• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Canaan Partners

chutes parachutes Turkey
Biotech

Recursion, Canaan, Metsera and more—Chutes & Ladders

Recursion plucks J&J chief data science officer. Canaan adds ex-Pfizer R&D leader as venture partner. Obesity-focused Metsera unveils leadership team.
Max Bayer , Gabrielle Masson Apr 19, 2024 8:30am
graphic of different bunches of USD bills in a pile

Canaan adds $100M-plus, Pfizer vet to guide fresh biotech bets

Apr 17, 2024 7:00am
Qlaris Bio CEO Thurein Htoo

Qlaris, with $25M round, pushes new glaucoma drug into clinic

Apr 15, 2021 7:30am
laboratory

Tyra banks $106M, adds to C-suite as it aims for clinic in 2022

Mar 31, 2021 11:00am
Day One Biopharmaceuticals CEO Jeremy Bender

Day One banks $130M to advance pan-RAF inhibitor

Feb 10, 2021 9:40am
Hippo head breaking the surface of the water

Vivace snares $30M to push Hippo-targeting drugs into clinic

Dec 16, 2020 11:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings